Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference32 articles.
1. Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT Trial: a secondary analysis of a randomized clinical trial;Fiuzat;JAMA Cardiol,2020
2. Contemporary treatment patterns and clinical outcomes of comorbid diabetes mellitus and HFrEF: the CHAMP-HF registry;Vaduganathan;J Am Coll Cardiol HF,2020
3. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association;Virani;Circulation,2020
4. Unlocking the secrets of mitochondria in the cardiovascular system: path to a cure in heart failure-a report from the 2018 National Heart, Lung, and Blood Institute Workshop;Tian;Circulation,2019
5. Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure;Karamanlidis;Cell Metab,2013
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. NAD in pathological cardiac remodeling: Metabolic regulation and beyond;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01
2. Mitochondrial dyshomeostasis in cardiac aging and related diseases;SCIENTIA SINICA Vitae;2023-11-02
3. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update;Advances in Nutrition;2023-11
4. NAD+depletion and altered mitochondrial function are key to the establishment of placental dysfunction in an inflammatory-driven subclass of preeclampsia;2023-09-09
5. Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects;Cell Reports Medicine;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3